Sort   by:  
 Page size 
MetabolomicsAquamin and Prevention of Colon Cancer (part-III)
Not available
ORGANISM(S): Homo sapiens 
ST001227 | MetabolomicsWorkbench
MetabolomicsAquamin and Prevention of Colon Cancer (part-II)
Not available
ORGANISM(S): Homo sapiens 
ST001226 | MetabolomicsWorkbench
MetabolomicsAquamin and Prevention of Colon Cancer (part-VI)
Not available
ORGANISM(S): Homo sapiens 
ST001230 | MetabolomicsWorkbench
MetabolomicsAquamin and Prevention of Colon Cancer (part-I)
Not available
ORGANISM(S): Homo sapiens 
ST001225 | MetabolomicsWorkbench
MetabolomicsAquamin and Prevention of Colon Cancer (part-V)
Not available
ORGANISM(S): Homo sapiens 
ST001229 | MetabolomicsWorkbench
MetabolomicsAquamin and Prevention of Colon Cancer (part-IV)
Not available
ORGANISM(S): Homo sapiens 
ST001228 | MetabolomicsWorkbench
MetabolomicsGeographic variation of mutagenic exposures in kidney cancer genomes

International differences in the incidence of many cancer types indicate the existence of carcinogen exposures that have not been identified by conventional epidemiology yet potentially make a substantial contribution to cancer burden1. This pertains to clear cell renal cell carcinoma (ccRCC), fo...

2024-03-26 | MTBLS9394 | MetaboLights
MetabolomicsIdentification of pre-diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis – a nested case-control study within the ATBC cohort

In pre-disposed individuals, a reprogramming of the hepatic lipid metabolism may support liver cancer initiation. We conducted a high-resolution mass spectrometry based untargeted lipidomics analysis of pre-diagnostic serum samples from a nested case-control study (219 liver cancer cases and 219 ...

2023-09-18 | MTBLS7776 | MetaboLights
MetabolomicsIdentification of Biomarkers Using Metabolomics: From Chronic Non-Atrophic Gastritis and Chronic Atrophic Gastritis to Gastric Cancer

Gastric cancer (GC) is a severe malignancy characterized by late diagnosis, poor prognosis and low survival rates. Its progression is often linked to chronic non-atrophic gastritis (CNAG) and chronic atrophic gastritis (CAG), which show atypical symptoms. Identifying biomarkers for CNAG, CAG and ...

2026-09-29 | MTBLS12186 | MetaboLights
MetabolomicsUnravelling altered RNA metabolism in pancreatic cancer cells by liquid-chromatography coupling to ion mobility mass spectrometry
Ion mobility coupling to mass spectrometry facilitates an increase of resolution and chromatographic peak-capacity. Further coupling to liquid chromatography results in multi-dimensional analytical methods, especially suitable for complex matrices with structurally similar compounds. Modified nucleo...
2019-05-16 | MTBLS812 | MetaboLights
Sort   by:  
 Page size